Cite
200 Complement drives Parkinson's disease neuropathology through activation of microglial C5a receptors.
MLA
Albornoz, Eduardo, and Trent Woodruff. “200 Complement Drives Parkinson’s Disease Neuropathology through Activation of Microglial C5a Receptors.” Immunobiology, vol. 228, no. 5, Sept. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.imbio.2023.152650.
APA
Albornoz, E., & Woodruff, T. (2023). 200 Complement drives Parkinson’s disease neuropathology through activation of microglial C5a receptors. Immunobiology, 228(5), N.PAG. https://doi.org/10.1016/j.imbio.2023.152650
Chicago
Albornoz, Eduardo, and Trent Woodruff. 2023. “200 Complement Drives Parkinson’s Disease Neuropathology through Activation of Microglial C5a Receptors.” Immunobiology 228 (5): N.PAG. doi:10.1016/j.imbio.2023.152650.